Medicine & Life Sciences
T-Lymphocytes
100%
Lymphoma
98%
T-Cell Lymphoma
43%
Lymphoma, Large B-Cell, Diffuse
42%
Neoplasms
36%
Nivolumab
33%
Immune System
29%
varlilumab
28%
Non-Hodgkin's Lymphoma
23%
Agent Orange
22%
Military Family
20%
Xylenes
17%
Therapeutics
16%
Toluene
16%
Clinical Trials
16%
Transplants
15%
Benzene
15%
Phase II Clinical Trials
15%
Survivorship
15%
Vietnam
14%
Organized Financing
14%
Drug Therapy
14%
Lymphoproliferative Disorders
14%
National Cancer Institute (U.S.)
14%
Antibodies
13%
Armed Conflicts
13%
Veterans
12%
B-Cell Lymphoma
12%
Ionizing Radiation
12%
Hematologic Neoplasms
12%
Immunotherapy
10%
Population
9%
B-Lymphocytes
9%
Poisons
9%
Randomized Controlled Trials
8%
Quality of Life
8%
Recurrence
7%
Health
6%